RE:RE:RE:RE:RE:New Proactive Investor InterviewYes we've been hearing those points for years, including the "de-risked" business. Funny enough they were using that talking point before 2016 after which the sales, gross margins, net income peaked and then declined. You would think a de-risked growth stage company wouldn't have played out like that.
You bring up a good point about the need for financing. Will the company have a few amazing quarters shortly before the financing, only for investors to realize that they weren't recurring sales? Will they be able to new find investors who aren't aware of what happened after the last financing? digitel wrote: "Got to admit Gagnon has a strange English, he used talk in superlatives about ceapro future and no deal comes for years, then he says interesting quarter and its the best ever. This time he said significant events (yes plural), so pick up what you want from it."
When he used to talk superlatives he did so in the context of the forward-looking statements with many technical hurdles still in front of him. Timing is always the most difficult and the hurdles were more time consuming than he originally imagined. It all took a couple of extra years to sort through. Now those hurdles are substantially behind de-risking the company and future timelines.
1. PGX patents received for the US, Europe, Canada, India.
2. New facility with 10X capacity fully certified by major clients.
3. Groundwork laid for large-scale integration of PGX.
4. Consumer panels, bioavailability studies, stability studies complete.
5. Significant Partnering discussions with all of the above in hand.
The next stage is partnering and sales given all accomplished.
The insiders kept virtually every single share and option on the run up to $2.50 and all of the way down. That suggests the kind of value they've been aiming at. They've always believed in the superlatives. They believe they have all of their ducks lined up now and are targeting the share price.
They have answered their dilemma and want to keep control of PGX in any deal. They will need financial backing given the costs of a new plant.